Brief: Mendus To Present Positive Interim Data From ALISON Trial In Ovarian Cancer
March 15 (Reuters) - Mendus AB (publ) IMMUN.ST :
* TO PRESENT POSITIVE INTERIM DATA FROM ALISON TRIAL IN
OVARIAN
CANCER AT AACR ANNUAL MEETING 2023
Source text for Eikon: ID:nGNE8lDJrf
Further company coverage: IMMUN.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))